|
| 36697218 | Cystic neutrophilic granulomatous mastitis: sensitivity and specificity of 16s rRNA and Sanger sequencing for <i>Corynebacterium</i> spp. | J Clin Pathol | 2024 |
| 37548751 | Redefining and capturing pre-analytic deficiencies in an anatomical pathology laboratory: a quality improvement initiative. | Virchows Arch | 2024 |
| 36103329 | Cytohistologic immunohistochemical correlation of epithelial tubo-ovarian neoplasms: Can cell blocks substitute for tissue? | Cancer Cytopathol | 2023 |
| 37958361 | <i>MLH1</i> Methylation Testing as an Integral Component of Universal Endometrial Cancer Screening-A Critical Appraisal. | Cancers (Basel) | 2023 |
| 37793305 | Budget impact analysis of molecular subtype profiling in endometrial cancer. | Gynecol Oncol | 2023 |
| 37222195 | Genomic profiling of dedifferentiated endometrial carcinomas arising in the background of high-grade carcinoma: a targeted next-generation sequencing study. | Histopathology | 2023 |
| 36860193 | Mesonephric-like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric-like carcinosarcomas. | Histopathology | 2023 |
| 36749312 | The Impact of the Pathologist in Multidisciplinary Cancer Conferences on Patient Care : Evidence From the Literature. | Am J Clin Pathol | 2023 |
| 36849702 | Molecular correlates of invasion pattern in HPV-associated endocervical adenocarcinoma: emergence of two distinct risk-stratified tiers. | Histopathology | 2023 |
| 34103388 | Three-antibody classifier for muscle invasive urothelial carcinoma and its correlation with p53 expression. | J Clin Pathol | 2022 |
| 36230835 | Development of a Clinically Applicable NanoString-Based Gene Expression Classifier for Muscle-Invasive Bladder Cancer Molecular Stratification. | Cancers (Basel) | 2022 |
| 35151601 | Combining CAPRA-S With Tumor IDC/C Features Improves the Prognostication of Biochemical Recurrence in Prostate Cancer Patients. | Clin Genitourin Cancer | 2022 |
| 35027623 | Upregulation of IFNÉ£-mediated chemokines dominate the immune transcriptome of muscle-invasive urothelial carcinoma. | Sci Rep | 2022 |
| 32471889 | Immune gene expression profiles in high-grade urothelial carcinoma of the bladder: a NanoString study. | J Clin Pathol | 2021 |
| 34509050 | Development of a multiplex immuno-oncology biomarker and digital pathology workflow for assessment of urothelial carcinoma. | Pathol Res Pract | 2021 |
| 32769429 | CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma: Correlation With Patient Outcome. | Am J Surg Pathol | 2021 |
| 31161221 | Temporal Stability and Prognostic Biomarker Potential of the Prostate Cancer Urine miRNA Transcriptome. | J Natl Cancer Inst | 2020 |
| 32081560 | A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade. | Urol Oncol | 2020 |
| 31782197 | Histological grading of ovarian mucinous carcinoma - an outcome-based analysis of traditional and novel systems. | Histopathology | 2020 |
| 33022560 | Can immune markers help identify fast relapse in patients with muscle invasive bladder cancer? | Pathol Res Pract | 2020 |
| 32471646 | The prognostic role of horizontal and circumferential tumor extent in cervical cancer: Implications for the 2019 FIGO staging system. | Gynecol Oncol | 2020 |
| 31558364 | An integrative DNA methylation model for improved prognostication of postsurgery recurrence and therapy in prostate cancer patients. | Urol Oncol | 2020 |
| 31605802 | Methylation Markers in Prostate Biopsies Are Prognosticators for Late Biochemical Recurrence and Therapy after Surgery in Prostate Cancer Patients. | J Mol Diagn | 2020 |
| 30679193 | International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome. | J Clin Pathol | 2019 |
| 30212391 | FIGO Versus Silverberg Grading Systems in Ovarian Endometrioid Carcinoma: A Comparative Prognostic Analysis. | Am J Surg Pathol | 2019 |
| 31200836 | GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture. | Eur Urol Oncol | 2019 |
| 31570428 | Pilot Study on the Utility of Circulating HER2/Neu Levels in the Serum of Breast Cancer Patients. | Anticancer Res | 2019 |
| 31335355 | p53, Mismatch Repair Protein, and POLE Abnormalities in Ovarian Clear Cell Carcinoma: An Outcome-based Clinicopathologic Analysis. | Am J Surg Pathol | 2019 |
| 30777394 | Combining urinary DNA methylation and cell-free microRNA biomarkers for improved monitoring of prostate cancer patients on active surveillance. | Urol Oncol | 2019 |
| 29246734 | Assessment of Serum microRNA Biomarkers to Predict Reclassification of Prostate Cancer in Patients on Active Surveillance. | J Urol | 2018 |
| 30470249 | A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer. | Clin Epigenetics | 2018 |
| 29428633 | Re: Urinary DNA Methylation Biomarkers for Noninvasive Prediction of Aggressive Disease in Patients with Prostate Cancer on Active Surveillance: F. Zhao, E. Olkhov-Mitsel, T. van der Kwast, J. Sykes, D. Zdravic, V. Venkateswaran, A. R. Zlotta, A. Loblaw, N. E. Fleshner, L. Klotz, D. Vesprini and B. Bapat J Urol 2017;197:335-341. | J Urol | 2018 |
| 27545574 | Urinary DNA Methylation Biomarkers for Noninvasive Prediction of Aggressive Disease in Patients with Prostate Cancer on Active Surveillance. | J Urol | 2017 |
| 28167242 | Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer. | Transl Oncol | 2017 |
| 28376164 | Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer. | J Natl Cancer Inst | 2017 |
| 28693181 | Distinct DNA methylation alterations are associated with cribriform architecture and intraductal carcinoma in Gleason pattern 4 prostate tumors. | Oncol Lett | 2017 |
| 24651255 | Novel multiplex MethyLight protocol for detection of DNA methylation in patient tissues and bodily fluids. | Sci Rep | 2014 |
| 25277202 | Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer. | Oncotarget | 2014 |
| 23461634 | Measuring kinetic isotope effects in enzyme reactions using time-resolved electrospray mass spectrometry. | Anal Chem | 2013 |
| 22505515 | Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there. | Biol Chem | 2012 |
| 22874102 | Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer. | Epigenetics | 2012 |
| 23342273 | Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers. | Cancer Med | 2012 |